This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jan;15(1):e1.

doi: 10.1016/S1470-2045(13)70557-6.

Biomarkers for immune checkpoint inhibitors

Lysanne A Lievense¹, Joost P J J Hegmans¹, Joachim G J V Aerts²

Affiliations

Affiliations

¹ Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
² Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: j.aerts@erasmusmc.nl.

PMID: 24384488
DOI: 10.1016/S1470-2045(13)70557-6

Comment

Biomarkers for immune checkpoint inhibitors

Lysanne A Lievense et al. Lancet Oncol. 2014 Jan.

. 2014 Jan;15(1):e1.

doi: 10.1016/S1470-2045(13)70557-6.

Authors

Lysanne A Lievense¹, Joost P J J Hegmans¹, Joachim G J V Aerts²

Affiliations

¹ Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
² Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: j.aerts@erasmusmc.nl.

PMID: 24384488
DOI: 10.1016/S1470-2045(13)70557-6

No abstract available

PubMed Disclaimer

Comment in

Biomarkers for immune checkpoint inhibitors--authors' reply.
Calabrò L, Maio M. Calabrò L, et al. Lancet Oncol. 2014 Jan;15(1):e1-2. doi: 10.1016/S1470-2045(13)70573-4. Lancet Oncol. 2014. PMID: 24384489 No abstract available.

Comment on

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.
Calabrò L, Morra A, Fonsatti E, Cutaia O, Amato G, Giannarelli D, Di Giacomo AM, Danielli R, Altomonte M, Mutti L, Maio M. Calabrò L, et al. Lancet Oncol. 2013 Oct;14(11):1104-1111. doi: 10.1016/S1470-2045(13)70381-4. Epub 2013 Sep 11. Lancet Oncol. 2013. PMID: 24035405 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information